These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21626113)

  • 21. [Clinical results and the mechanism of bone healing for the repair of bone defects due to tumor resection with novel interporous TCP].
    Sang H; Wang Z; Guo Z; Wang L; Li J; Meng G; Li X; Lu J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Apr; 22(4):463-7. PubMed ID: 18575450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of calcium chloride and aprotinin in the in vivo biological performance of a composite combining biphasic calcium phosphate granules and fibrin sealant.
    Le Guehennec L; Goyenvalle E; Aguado E; Pilet P; Spaethe R; Daculsi G
    J Mater Sci Mater Med; 2007 Aug; 18(8):1489-95. PubMed ID: 17387594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biphasic ceramic bone substitute mixed with autogenous bone marrow in the treatment of cavitary benign bone lesions.
    El-Adl G; Mostafa MF; Enan A; Ashraf M
    Acta Orthop Belg; 2009 Feb; 75(1):110-8. PubMed ID: 19358408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biphasic ceramics and fibrin sealant for bone reconstruction in ear surgery.
    Bagot d'Arc M; Daculsi G; Emam N
    Ann Otol Rhinol Laryngol; 2004 Sep; 113(9):711-20. PubMed ID: 15453528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healing of ungrafted bone defects of the talus after benign tumour removal.
    Shears E; Dehne K; Murata H; Abudu A; Grimer RJ; Tillman RM; Carter SR
    Foot Ankle Surg; 2008; 14(3):161-5. PubMed ID: 19083636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural Course of Local Bone Mineralization After Treatment of Benign or Borderline Bone Tumors and Cysts With a Composite Ceramic Bone Graft Substitute.
    Horstmann PF; Hettwer WH; Petersen MM
    J Clin Densitom; 2018; 21(4):472-479. PubMed ID: 29661685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience with the artificial bone graft substitute Calcibon used following curettage of benign and low-grade malignant bone tumors.
    Friesenbichler J; Maurer-Ertl W; Bergovec M; Holzer LA; Ogris K; Leitner L; Leithner A
    Sci Rep; 2017 May; 7(1):1736. PubMed ID: 28496119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major bone defect treatment with an osteoconductive bone substitute.
    Paderni S; Terzi S; Amendola L
    Chir Organi Mov; 2009 Sep; 93(2):89-96. PubMed ID: 19711008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curettage and graft alleviates athletic-limiting pain in benign lytic bone lesions.
    Moretti VM; Slotcavage RL; Crawford EA; Lackman RD; Ogilvie CM
    Clin Orthop Relat Res; 2011 Jan; 469(1):283-8. PubMed ID: 20461483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of hydroxyapatite to fill cavities after excision of benign bone tumours. Clinical results.
    Yamamoto T; Onga T; Marui T; Mizuno K
    J Bone Joint Surg Br; 2000 Nov; 82(8):1117-20. PubMed ID: 11132269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of a calcium sulfate-calcium phosphate synthetic bone graft composite in the surgical management of primary bone tumors.
    Evaniew N; Tan V; Parasu N; Jurriaans E; Finlay K; Deheshi B; Ghert M
    Orthopedics; 2013 Feb; 36(2):e216-22. PubMed ID: 23380017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone regeneration following injection of mesenchymal stem cells and fibrin glue with a biodegradable scaffold.
    Yamada Y; Boo JS; Ozawa R; Nagasaka T; Okazaki Y; Hata K; Ueda M
    J Craniomaxillofac Surg; 2003 Feb; 31(1):27-33. PubMed ID: 12553923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a novel bone graft substitute in peri-articular bone tumours of the knee.
    Schindler OS; Cannon SR; Briggs TW; Blunn GW
    Knee; 2007 Dec; 14(6):458-64. PubMed ID: 17869519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of benign and borderline bone tumors with combined curettage and bone defect reconstruction.
    Horstmann PF; Hettwer WH; Petersen MM
    J Orthop Surg (Hong Kong); 2018; 26(3):2309499018774929. PubMed ID: 30428758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Patient medical rehabilitation following osteoplastic operations using hydroxylapatite-based porous ceramic].
    Protsenko VV; Tolstopiatov BA
    Lik Sprava; 1999 Jul; (5):71-3. PubMed ID: 10822683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Synthetic calcium phosphate ceramics in secondary alveoloplasty].
    Corre P; Khonsari RH; Laure B; Elamrani K; Weiss P; Mercier JM
    Rev Stomatol Chir Maxillofac; 2012 Apr; 113(2):131-5. PubMed ID: 22306772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Clinical and Radiological Experience with a Ceramic Bone Graft Substitute in the Treatment of Benign and Borderline Bone Lesions.
    Horstmann PF; Hettwer WH; Kaltoft NS; Petersen MM
    Sci Rep; 2018 Oct; 8(1):15384. PubMed ID: 30337629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of calcium hydroxyapatite ceramic in bone tumour surgery.
    Uchida A; Araki N; Shinto Y; Yoshikawa H; Kurisaki E; Ono K
    J Bone Joint Surg Br; 1990 Mar; 72(2):298-302. PubMed ID: 2155908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of extended curettage with osteotomy and fenestration followed by reconstruction with conservation of muscle insertion in the treatment of Enneking stage II locally aggressive bone tumor of the proximal extremities: resection and treatment of bone tumors.
    Chen F; Xia J; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J
    World J Surg Oncol; 2013 Mar; 11():54. PubMed ID: 23497479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MBCP biphasic calcium phosphate granules and tissucol fibrin sealant in rabbit femoral defects: the effect of fibrin on bone ingrowth.
    Le Guehennec L; Goyenvalle E; Aguado E; Pilet P; Bagot D'Arc M; Bilban M; Spaethe R; Daculsi G
    J Mater Sci Mater Med; 2005 Jan; 16(1):29-35. PubMed ID: 15754141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.